Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred

被引:0
|
作者
Haddad, L
Day, INM
Hunt, S
Williams, RR
Humphries, SE
Hopkins, PN
机构
[1] Univ Utah, Dept Internal Med, Salt Lake City, UT 84108 USA
[2] Univ London Univ Coll, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England
关键词
familial hypercholesterolemia; LDLR gene; APOB gene; microsatellites;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monogenically inherited hypercholesterolemia is most commonly caused by mutations at the low density lipoprotein receptor (LDLR) locus causing familial hypercholesterolemia (FH) or at the apolipoprotein B (APOB) locus causing the disorder familial defective apoB (FDB), Probands from 47 kindreds with a strict clinical diagnosis of FH were selected from the Cardiovascular Genetics Research Lipid Clinic, Utah, for molecular genetic analysis. Using a combination of single-strand conformation polymorphism (SSCP) and direct sequencing, 12 different LDLR gene mutations were found in 16 of the probands, Three of the probands were carriers of the APOB R3500Q mutation. In five of the remaining 28 pedigrees where no mutation had been detected, samples from enough relatives were available to examine co-segregation with the LDLR region using the microsatellite marker D19S221, which is within 1 Mb centromeric of the LDLR locus, and D19S394, sited within 150 kb telomeric of the LDLR locus. In four of the families there was strong evidence for co-segregation between the LDLR locus and the phenotype of hypercholesterolemia, but in one large family with 18 living affected members and clear-cut bimodal hypercholesterolemia, there were numerous exclusions of co-segregation. Using length polymorphic markers within and outside the APOB gene, linkage of phenotype in this family to the APOB region was similarly excluded. In this large family, the degree of hypercholesterolemia, prevalence of tendon xanthomata, and occurrence of early coronary disease were indistinguishable from the other families studied. j/r In summary the data pro,ide unequivocal evidence that a third locus can be etiological for monogenic familial hypercholesteralemia and should be reinvigorating to research in this field., Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred.
引用
收藏
页码:1113 / 1122
页数:10
相关论文
共 28 条
  • [1] Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-apo B kindred
    Humphries, SE
    Haddad, L
    Day, INM
    Huni, S
    Hopkins, P
    Williams, RR
    ATHEROSCLEROSIS, 1998, 140 (02) : 380 - 380
  • [2] Evaluation of the respective contributions of LDLR, ApoB, and non LDLR/non ApoB gene defects to autosomal dominant type IIa hypercholesterolemia.
    Varret, M
    Saint-Jore, B
    Dachet, C
    Rabes, JP
    Devillers, M
    Collod-Beroud, G
    Junien, C
    Boileau, C
    CIRCULATION, 2000, 102 (18) : 277 - 277
  • [3] Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred
    Hunt, SC
    Hopkins, PN
    Bulka, K
    McDermott, MT
    Thorne, TL
    Wardell, BB
    Bowen, BR
    Ballinger, DG
    Skolnick, MH
    Samuels, ME
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) : 1089 - 1093
  • [4] Genetic Polymorphisms in LDLR, APOB, PCSK9 and Other Lipid Related Genes Associated with Familial Hypercholesterolemia in Malaysia
    Lye, Say-Hean
    Chahil, Jagdish Kaur
    Bagali, Pramod
    Alex, Livy
    Vadivelu, Jamunarani
    Ahmad, Wan Azman Wan
    Chan, Siew-Pheng
    Thong, Meow-Keong
    Zain, Shamsul Mohd
    Mohamed, Rosmawati
    PLOS ONE, 2013, 8 (04):
  • [5] In-silico analysis of non-synonymous SNPs of human LDLR gene and their impact on familial hypercholesterolemia
    Ghosh, Pratik
    Ghosh, Samarpita
    Behera, Bhaskar
    Behera, Jiban Kumar
    Bhattacharya, Manojit
    Kar, Niladri Bhusan
    GENE REPORTS, 2021, 23
  • [6] Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
    Berta, Eszter
    Zsiros, Noemi
    Bodor, Miklos
    Balogh, Istvan
    Lorincz, Hajnalka
    Paragh, Gyorgy
    Harangi, Mariann
    GENES, 2022, 13 (07)
  • [7] Generation and LDLR Functional Correction of Familial Hypercholesterolemia iPSC With Physiologically Responsive Non-Integrating BAC Vector
    Ramakrishnan, Venkat M.
    Yang, Jeong Yeh
    Burchell, Patrick
    Tien, Kevin T.
    Bocard, Braden R.
    Maijub, John G.
    Williams, Stuart K.
    Wade-Martins, Richard
    West, Franklin D.
    Boyd, Nolan L.
    CIRCULATION, 2014, 130
  • [8] Identification of novel genetic mutations in low-density lipoprotein receptor (LDLR) gene causing familial hypercholesterolemia in Saudi Arab homozygous children
    Al-Allaf, F. A.
    Athar, M.
    Abduljaleel, Z.
    Taher, M. M.
    Bouazzaoui, A.
    Abalkhail, H.
    Own, R.
    Al-Allaf, A. F.
    AboMansoor, I
    Azhar, Z.
    Ba-hammam, F.
    Alashwal, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 294 - 294
  • [9] Genetic heterogeneity in familial hypobetalipoproteinemia: Linkage and non-linkage to the ApoB gene in Caucasian families
    Pulai, JI
    Neuman, RJ
    Groenewegen, AW
    Wu, JS
    Schonfeld, G
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 76 (01): : 79 - 86
  • [10] NON-FUNCTIONALITY OF THREE LDL-R AND APOB GENE MUTATIONS THAT WERE ASSUMED TO CAUSE FAMILIAL HYPERCHOLESTEROLEMIA
    Huijgen, R.
    Kindt, I.
    Fouchier, S.
    Defesche, J.
    Hutten, B.
    Kastelein, J.
    Vissers, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)